Justin J. Sherman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Justin J. Sherman has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Brett L. Smith
Clinical Instructor of Pharmacy Practice. School of Pharmacy, University of Mississippi. Jackson, MS (United States).
1 shared publication - Christa D. Johnson
St. Dominic Hospital, 969 Lakeland Drive, Jackson, MS 39216, United States
1 shared publication Corey McEwen
Department of Pharmacy Practice, University of Mississippi School of Pharmacy, Jackson, MS, USA
1 shared publicationDaniel M. Riche
1 shared publication- Elizabeth B. Hearn
University of Mississippi School of Pharmacy, 2500 North State Street, Jackson, MS 39216, United States
1 shared publication Emmanuel R. Hodge
Department of Pharmacy Practice, University of Mississippi School of Pharmacy 1 , Jackson, MS
1 shared publication
Latest Publications
- 23 January 2025
- Published by American Diabetes Association in Clinical Diabetes
- Vol. 43 (3) , 445-448
Artifactual Hypoglycemia Caused by Raynaud’s Phenomenon in a Person With Diabetes
- 23 January 2025
- Published by American Diabetes Association in Clinical Diabetes
- Vol. 43 (3) , 445-448
Artifactual Hypoglycemia Caused by Raynaud’s Phenomenon in a Person With Diabetes
- Open Access
- 1 February 2021
- Published by American Diabetes Association in Diabetes Spectrum
- Vol. 34 (1) , 73-75
Injection-Site Nodules Associated With Once-Weekly Subcutaneous Administration of Semaglutide
Glucagon-like peptide 1 (GLP-1) receptor agonists are a safe and effective treatment option for patients with type 2 diabetes (1). Selective activation of the G
- 1 February 2021
- Published by American Diabetes Association in Diabetes Spectrum
- Vol. 34 (1) , 73-75
Open AccessInjection-Site Nodules Associated With Once-Weekly Subcutaneous Administration of Semaglutide
Glucagon-like peptide 1 (GLP-1) receptor agonists are a safe and effective treatment option for patients with type 2 diabetes (1). Selective activation of the G
- 1 November 2020
- Published by American Diabetes Association in Diabetes Spectrum
- Vol. 33 (4) , 347-351
Glucagon Therapy: A Comparison of Current and Novel Treatments
- 1 November 2020
- Published by American Diabetes Association in Diabetes Spectrum
- Vol. 33 (4) , 347-351
Glucagon Therapy: A Comparison of Current and Novel Treatments
- 1 May 2019
- Published by Elsevier in Currents in Pharmacy Teaching and Learning
- Vol. 11 (5) , 513-521
Assessment of pharmacy students' patient care skills using case scenarios with a SOAP note grading rubric and standardized patient feedback
- 1 May 2019
- Published by Elsevier in Currents in Pharmacy Teaching and Learning
- Vol. 11 (5) , 513-521
Assessment of pharmacy students' patient care skills using case scenarios with a SOAP note grading rubric and standardized patient feedback
- Open Access
- 31 March 2019
- Published by JCFCorp SG PTE LTD in Pharmacy Practice
- Vol. 17 (1) , 1302
Effect of a smoking cessation educational intervention on knowledge and confidence of pharmacy students versus community leaders
Pharmacy Practice is a free full-text journal with a scope on the practice of pharmacy. Pharmacy Practice covers pharmaceutical care, social pharmacy, pharmacy education, process and outcome research, health promotion and education, health informatics, pharmacoepidemiology
- 31 March 2019
- Published by JCFCorp SG PTE LTD in Pharmacy Practice
- Vol. 17 (1) , 1302
Open AccessEffect of a smoking cessation educational intervention on knowledge and confidence of pharmacy students versus community leaders
Pharmacy Practice is a free full-text journal with a scope on the practice of pharmacy. Pharmacy Practice covers pharmaceutical care, social pharmacy, pharmacy education, process and outcome research, health promotion and education, health informatics, pharmacoepidemiology
- 3 January 2012
- Published by SAGE Publications in Journal of Pharmacy Practice
- Vol. 25 (2) , 164-168
Prescriber Monitoring for Benign Prostatic Hyperplasia Within a Family Medicine Clinic
Purpose: The purpose of this study was to compare prescriber monitoring for safety and efficacy of medication classes used to treat benign prostatic hyperplasia (BPH). Methods: This was a retrospective chart review of patients diagnosed with BPH who were prescribed medications within a family medicine clinic between January 2008 and August 2010. Patients were divided into those receiving nonselective and uroselective alpha-blockers, 5-alpha reductase inhibitors (5-ARIs), and combination therapy. A chart review was performed with regard to predetermined criteria to monitor how efficacy and adverse effects were assessed by providers in the clinic. Results: A general genitourinary assessment was documented most frequently for patients receiving 5-ARIs and least frequently in patients receiving nonselective alpha-blockers. A digital rectal examination was documented in 11% of patients. Prostate-specific antigen concentrations were assessed evenly across all medication classes and documented in 47% of eligible patients. However, the American Urological Association Symptom Index and quality-of-life questions were not performed on any patients, and assessments of adverse effects were not documented. Conclusion: Although prescribers in a family medicine clinic recorded a general genitourinary assessment for patients receiving BPH medications, a more standardized approach is needed.
- 3 January 2012
- Published by SAGE Publications in Journal of Pharmacy Practice
- Vol. 25 (2) , 164-168
Prescriber Monitoring for Benign Prostatic Hyperplasia Within a Family Medicine Clinic
Purpose: The purpose of this study was to compare prescriber monitoring for safety and efficacy of medication classes used to treat benign prostatic hyperplasia (BPH). Methods: This was a retrospective chart review of patients diagnosed with BPH who were prescribed medications within a family medicine clinic between January 2008 and August 2010. Patients were divided into those receiving nonselective and uroselective alpha-blockers, 5-alpha reductase inhibitors (5-ARIs), and combination therapy. A chart review was performed with regard to predetermined criteria to monitor how efficacy and adverse effects were assessed by providers in the clinic. Results: A general genitourinary assessment was documented most frequently for patients receiving 5-ARIs and least frequently in patients receiving nonselective alpha-blockers. A digital rectal examination was documented in 11% of patients. Prostate-specific antigen concentrations were assessed evenly across all medication classes and documented in 47% of eligible patients. However, the American Urological Association Symptom Index and quality-of-life questions were not performed on any patients, and assessments of adverse effects were not documented. Conclusion: Although prescribers in a family medicine clinic recorded a general genitourinary assessment for patients receiving BPH medications, a more standardized approach is needed.
- 1 October 2011
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 75 (8) , 156
Physical Assessment Experience in a Problem-Based Learning Course
Objective. To evaluate the impact of a physical-assessment learning experience implemented in the problem-based learning (PBL) format of the third year of a doctor of pharmacy (PharmD) program.Design. Students enrolled in a PBL course completed survey instruments to measure knowledge and confidence before and after participating in the learning experience. A simulation stethoscope was used to teach students abnormal pulmonary and cardiovascular sounds in 1-hour sessions for each of 12 PBL groups.Assessment. The 92 students enrolled in the PBL course completed pre- and post-experience survey instruments. Students’ scores on knowledge questions increased significantly (p < 0.0001) from 40.4% ± 11.4% at baseline to 62.5% ± 13.7% and 63.1 ± 11.6%, respectively, on the 2 sets of post-experience questions. Students scored a median of 3 or 4 on a 5-point Likert scale after a learning experience on questions measuring confidence.Conclusion. Use of a simulation stethoscope in a physical-assessment learning experie...
- 1 October 2011
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 75 (8) , 156
Physical Assessment Experience in a Problem-Based Learning Course
Objective. To evaluate the impact of a physical-assessment learning experience implemented in the problem-based learning (PBL) format of the third year of a doctor of pharmacy (PharmD) program.Design. Students enrolled in a PBL course completed survey instruments to measure knowledge and confidence before and after participating in the learning experience. A simulation stethoscope was used to teach students abnormal pulmonary and cardiovascular sounds in 1-hour sessions for each of 12 PBL groups.Assessment. The 92 students enrolled in the PBL course completed pre- and post-experience survey instruments. Students’ scores on knowledge questions increased significantly (p < 0.0001) from 40.4% ± 11.4% at baseline to 62.5% ± 13.7% and 63.1 ± 11.6%, respectively, on the 2 sets of post-experience questions. Students scored a median of 3 or 4 on a 5-point Likert scale after a learning experience on questions measuring confidence.Conclusion. Use of a simulation stethoscope in a physical-assessment learning experie...